PCR-monitoring of minimal residual leukaemia after conventional chemotherapy and bone marrow transplantation in BCR-ABL-positive acute lymphoblastic leukaemia

Br J Haematol. 1995 Apr;89(4):937-41. doi: 10.1111/j.1365-2141.1995.tb08444.x.

Abstract

We report the results of consecutive tests in nine BCR-ABL-positive ALL patients by one-step and two-step (nested primer) reverse transcriptase-polymerase chain reaction (RT-PCR). Six patients could be tested in complete haematological remission (CHR). One patient remained one-step positive; four patients became one-step negative, but remained two-step positive; only one patient became two-step negative. In five patients the haematological relapse was preceded by one-step positivity by 1.5-5 weeks. In two patients who received autologous BMT in CHR, BCR-ABL was still detectable by two-step PCR, whereas allogeneic BMT was able to transiently reduce BCR-ABL below the two-step detection level. Our results show that one-step combined with two-step RT-PCR analysis gives valuable information about the efficacy of treatment and the dynamics of the leukaemic clone.

MeSH terms

  • Adult
  • Antineoplastic Agents / therapeutic use*
  • Bone Marrow Transplantation*
  • Fusion Proteins, bcr-abl / analysis
  • Humans
  • Middle Aged
  • Neoplasm, Residual / diagnosis*
  • Polymerase Chain Reaction
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy*

Substances

  • Antineoplastic Agents
  • Fusion Proteins, bcr-abl